- Home
- APLE vs HCM Comparison
APLE vs HCM Comparison
Compare APLE & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLE | HCM |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLE | HCM |
|---|---|---|
| Price | $12.40 | $14.95 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 7 | 1 |
| Target Price | ★ $14.14 | $13.75 |
| AVG Volume (30 Days) | ★ 2.2M | 44.6K |
| Earning Date | 02-23-2026 | 08-07-2025 |
| Dividend Yield | ★ 8.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | 0.53 |
| Revenue | ★ $1,418,986,000.00 | $602,197,000.00 |
| Revenue This Year | $0.53 | N/A |
| Revenue Next Year | $2.22 | $15.54 |
| P/E Ratio | $16.90 | ★ $5.58 |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $10.44 | $11.51 |
| 52 Week High | $16.02 | $19.50 |
Technical Indicators
Market Signals| Indicator | APLE | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 64.80 |
| Support Level | $11.88 | $14.63 |
| Resistance Level | $12.65 | $15.00 |
| Average True Range (ATR) | 0.26 | 0.40 |
| MACD | 0.03 | 0.22 |
| Stochastic Oscillator | 71.89 | 83.57 |
Price Performance
Historical ComparisonAbout APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.